MedPath

A prospective observational study of T cell subsets after administration of immune checkpoint inhibitors in patients with lung cancer

Not Applicable
Recruiting
Conditions
ung cancer
Registration Number
JPRN-UMIN000043565
Lead Sponsor
Kobe City Medical Center General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

inappropriate by the investigator and the investigator

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in T cell subsets
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath